4 days ago
SEPN
AnalystsDerek ArchilaDerek Archila's Stock Forecasts
AnalystsDerek Archila
Analyst Ranking
Top 2%
#91 out of 5556 analysts
Average Return
+25.5%
Win Rate
60%129 out of 215
Risk vs Reward
Poor
Good
Derek Archila's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +1,563.62% | $0.87 | $14.54 | 2022-09-14 - 2023-09-13 | Strong Buy |
Alumis IncALMS | +621.65% | $3.88 | $28.00 | 2025-07-25 - 2026-07-24 | Strong Buy |
Prometheus Biosciences IncRXDX | +604.58% | $27.52 | $193.90 | 2022-05-13 - 2023-05-12 | Strong Buy |
Prometheus Biosciences IncRXDX | +294.01% | $50.74 | $199.92 | 2022-08-29 - 2023-06-15 | Strong Buy |
Anaptysbio IncANAB | +204.79% | $15.02 | $45.78 | 2024-12-12 - 2025-12-11 | Strong Buy |
Derek Archila Analyst Color
Get additional color on Derek Archila's coverage of popular stocks
19 days ago
IRON
25 days ago
ARGX
a month ago
TRAX
2 months ago
IRON
2 months ago
PYXS
2 months ago
ARGX
3 months ago
BBIO
3 months ago
CLDX
3 months ago
TRAX
4 months ago
VRDN
5 months ago
RYTM
5 months ago
ARGX
6 months ago
ALMS
6 months ago
CLDX
6 months ago
ARGX
8 months ago
RYTM
8 months ago
IRON
9 months ago
IRON
10 months ago
ARGX
10 months ago
SLNO
10 months ago
RYTM
10 months ago
BBIO
10 months ago
ASND
10 months ago
ASND
Derek Archila's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atyr Pharma IncATYR | 4 | Hold | $4.00 | -37.01% | Maintains | 2 days ago |
Monte Rosa Therapeutics IncGLUE | 12 | Strong Buy | $25.00 | +136.52% | Maintains | 2 days ago |
Viridian Therapeutics IncVRDN | 6 | Strong Buy | $34.00 | +19.34% | Maintains | 3 days ago |
Septerna IncSEPN | 8 | Strong Buy | $61.00 | +24.87% | Maintains | 4 days ago |
Nurix Therapeutics IncNRIX | 11 | Hold | $20.00 | +30.72% | Maintains | 4 days ago |
Incyte CorpINCY | 15 | Hold | $127.00 | +6.14% | Maintains | 9 days ago |
Alnylam Pharmaceuticals IncALNY | 7 | Hold | $220.00 | +41.08% | Maintains | 9 days ago |
Xencor IncXNCR | 1 | Strong Buy | $44.00 | +23.08% | Maintains | 12 days ago |
Argenx SeARGX | 21 | Strong Buy | $1,336.00 | +44.09% | Maintains | 16 days ago |
Disc Medicine IncIRON | 5 | Strong Buy | $124.00 | +57.14% | Maintains | 19 days ago |
First Tracks Biotherapeutics IncTRAX | 3 | Strong Buy | $70.00 | +46.14% | Maintains | a month ago |
Pyxis Oncology IncPYXS | 2 | Strong Buy | $19.00 | +1,044.58% | Maintains | 2 months ago |
Alumis IncALMS | 4 | Strong Buy | $25.00 | +314.59% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 11 | Strong Buy | $151.00 | +14.63% | Maintains | 2 months ago |
Cabaletta Bio IncCABA | 13 | Hold | $3.00 | +130.77% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $102.00 | +37.30% | Maintains | 3 months ago |
Arvinas IncARVN | 9 | Hold | $11.00 | +71.61% | Downgrades | 3 months ago |
Celldex Therapeutics IncCLDX | 7 | Strong Buy | $72.00 | +141.04% | Maintains | 3 months ago |
Q32 Bio IncQTTB | 3 | Strong Buy | $66.00 | +613.51% | Upgrades | 4 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $11.00 | +245.91% | Initiates Coverage On | 4 months ago |
Rhythm Pharmaceuticals IncRYTM | 11 | Strong Buy | $155.00 | +38.05% | Maintains | 5 months ago |
Ascendis Pharma AASND | 16 | Strong Buy | $326.00 | +26.94% | Maintains | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 14 | Hold | $41.00 | -0.07% | Downgrades | 7 months ago |
Soleno Therapeutics IncSLNO | 5 | Hold | $53.00 | -0.02% | Downgrades | 7 months ago |
Alx Oncology Holdings IncALXO | 1 | Strong Buy | $5.00 | +332.90% | Initiates Coverage On | 8 months ago |
Ventyx Biosciences IncVTYX | 6 | Hold | $14.00 | 0.00% | Downgrades | 10 months ago |
Kyverna Therapeutics IncKYTX | 4 | Strong Buy | $33.00 | +576.23% | Maintains | a year ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $25.00 | +183.45% | Maintains | a year ago |
Annexon IncANNX | 4 | Strong Buy | $27.00 | +542.86% | Maintains | a year ago |
Anaptysbio IncANAB | 4 | Strong Buy | $81.00 | N/A | Maintains | a year ago |
Exelixis IncEXEL | 4 | Hold | $30.00 | N/A | Maintains | a year ago |
Kezar Life Sciences IncKZR | 12 | Hold | $5.00 | N/A | Maintains | a year ago |
C4 Therapeutics IncCCCC | 6 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Sutro Biopharma IncSTRO | 1 | Hold | $30.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 5 | Hold | $5.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $129.00 | N/A | Downgrades | a year ago |
Zymeworks IncZYME | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Immunovant IncIMVT | 9 | Strong Buy | $45.00 | N/A | Maintains | 2 years ago |
Acelyrin IncSLRN | 5 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Morphosys AgMOR | 4 | Hold | $18.25 | N/A | Downgrades | 3 years ago |
Dice Therapeutics IncDICE2 | 2 | Hold | $48.00 | N/A | Maintains | 3 years ago |
Morphic Holding IncMORF | 5 | Strong Buy | $80.00 | N/A | Maintains | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Hold | $116.50 | N/A | Downgrades | 4 years ago |
Prometheus Biosciences IncRXDX | 4 | Strong Buy | $71.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $71.00 | N/A | Initiates Coverage On | 5 years ago |
Esperion Therapeutics IncESPR | 1 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $24.00 | N/A | Upgrades | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Hold | $52.50 | N/A | Downgrades | 6 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 6 years ago |
Inventiva SaIVA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 6 years ago |
Genfit SaGNFTY | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Lakefront Biotherapeutics NvLKFT | 1 | Hold | $193.00 | N/A | Downgrades | 6 years ago |
Viela Bio IncVIE | 1 | Hold | $58.00 | N/A | Initiates Coverage On | 6 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Upgrades | 6 years ago |
Oneok IncOKE | 1 | Strong Buy | $41.00 | N/A | Reiterates | 7 years ago |
Amarin Corp PLCAMRN | 3 | Hold | $160.00 | N/A | Maintains | 7 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $32.00 | N/A | Maintains | 7 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $60.00 | N/A | Downgrades | 7 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $29.00 | N/A | Downgrades | 8 years ago |
Heron Therapeutics IncHRTX | 2 | Buy | $50.00 | N/A | Maintains | 8 years ago |
Urogen Pharma LtdURGN | 1 | Buy | $51.00 | N/A | Maintains | 9 years ago |
Perrigo Co PLCPRGO | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 9 years ago |
Pacira Biosciences IncPCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 9 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.